Evaluating Candidate Principal Surrogate Endpoints

DOI10.1111/j.1541-0420.2008.01014.xzbMath1152.62389OpenAlexW4300780642WikidataQ43070037 ScholiaQ43070037MaRDI QIDQ3549407

Peter B. Gilbert, Michael G. Hudgens

Publication date: 22 December 2008

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc2726718

zbMATH Keywords

clinical trialcausal inferenceprincipal stratificationstructural modelPrentice criteriaHIV vaccinecase cohortpostrandomization selection bias

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Estimation in survival analysis and censored data (62N02)

Related Items (29)

Comparing Biomarkers as Principal Surrogate Endpoints ⋮ On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints ⋮ Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption ⋮ A unified evaluation of differential vaccine efficacy ⋮ Robust methods to correct for measurement error when evaluating a surrogate marker ⋮ Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy ⋮ Testing for Heterogeneity in the Utility of a Surrogate Marker ⋮ Evaluation of longitudinal surrogate markers ⋮ Exploiting multiple outcomes in Bayesian principal stratification analysis with application to the evaluation of a job training program ⋮ Rejoinder ⋮ A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint ⋮ A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials ⋮ Predicting overall vaccine efficacy in a new setting by re-calibrating baseline covariate and intermediate response endpoint effect modifiers of type-specific vaccine efficacy ⋮ A causal framework for surrogate endpoints with semi-competing risks data ⋮ Assessing the value of a censored surrogate outcome ⋮ Bayesian methods for multiple mediators: relating principal stratification and causal mediation in the analysis of power plant emission controls ⋮ Discussion on “Surrogate Measures and Consistent Surrogates” ⋮ Discussion on “Surrogate Measures and Consistent Surrogates” ⋮ Causal inference: a missing data perspective ⋮ Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials ⋮ An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference ⋮ A Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference Framework ⋮ Augmented Designs to Assess Principal Strata Direct Effects ⋮ Identification of causal effects within principal strata using auxiliary variables ⋮ Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials ⋮ Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling ⋮ Assessing Vaccine Effects in Repeated Low‐Dose Challenge Experiments ⋮ Using Secondary Outcomes to Sharpen Inference in Randomized Experiments With Noncompliance ⋮ Surrogate Measures and Consistent Surrogates

Cites Work

• An analytic method for randomized trials with informative censoring. I
• Principal Stratification in Causal Inference
• A case-cohort design for epidemiologic cohort studies and disease prevention trials
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
• Augmented Designs to Assess Immune Response in Vaccine Trials
• Evaluating the Predictiveness of a Continuous Marker

This page was built for publication: Evaluating Candidate Principal Surrogate Endpoints